Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/8/24 19:00 | 2/8/24 | LCTX | Health | BioPrd | Biological Products, (No Diag | Bailey Don M | CA | D | P | 100 | 1.04 | 0 | 96 | 153 | 159 | I | |||||||||||||||
2/8/24 18:58 | 2/6/24 | LCTX | Health | BioPrd | Biological Products, (No Diag | Broadwood Partners, L.P. | NY | DT | P | 7,000 | 1.04 | 0 | 6,731 | 9 | 83,420 | M | |||||||||||||||
1/2/24 19:08 | 12/29/23 | LCTX | Health | BioPrd | Biological Products, (No Diag | Jayasuriya Anula | CA | D | P | 11 | 1.09 | 0 | 10 | New | 10 | D | |||||||||||||||
4/4/22 16:05 | 3/31/22 | LCTX | Health | BioPrd | Biological Products, (No Diag | Culley Brian M | CA | DO | P,CEO | P.d | 10 | 1.53 | 0 | 6 | 7 | 98 | D | ||||||||||||||
3/29/22 16:15 | 3/28/22 | LCTX | Health | BioPrd | Biological Products, (No Diag | Amin Dipti | CA | D | P | 57 | 1.63 | 0 | 35 | New | 35 | D | |||||||||||||||
3/28/22 19:22 | 3/25/22 | LCTX | Health | BioPrd | Biological Products, (No Diag | Culley Brian M | CA | DO | P,CEO | P | 7 | 1.38 | 0 | 5 | 7 | 81 | D | ||||||||||||||
3/25/22 17:56 | 3/23/22 | LCTX | Health | BioPrd | Biological Products, (No Diag | Broadwood Partners, L.P. | NY | DT | P.m | 1,318 | 1.42 | 0 | 930 | 1 | 69,959 | M | |||||||||||||||
3/25/22 16:15 | 3/24/22 | LCTX | Health | BioPrd | Biological Products, (No Diag | Mulroy Michael H. | CA | D | P | 10 | 1.40 | 0 | 7 | 3 | 259 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |